Lingor Paul, Koeberle Paulo, Kügler Sebastian, Bähr Mathias
Department of Neurology, University of Göttingen, Faculty of Medicine, S2-Laboratory, Waldweg 33, 37073 Göttingen, Germany.
Brain. 2005 Mar;128(Pt 3):550-8. doi: 10.1093/brain/awh382. Epub 2005 Jan 19.
Transection of the optic nerve induces an apoptotic degeneration of retinal ganglion cells (RGC) in the rat retina. The immediate early gene c-Jun, the proapoptotic Bcl-2 family member Bax and the apoptosome constituent Apaf-1 have been shown previously to play major roles in the induction or execution of the apoptosis cascade. In this study we have designed and generated short interfering RNAs (siRNAs) against c-Jun, Bax and Apaf-1, which were injected into the optic nerve stump in order to inhibit axotomy-induced apoptosis. siRNAs were first tested in vitro to ensure silencing efficiency. In vivo, a clear neuronal localization of Cy3-labelled siRNA could be visualized in retinal flat mounts. Retinas that were injected with anti-Apaf-1- and anti-c-Jun-siRNA showed significantly more surviving RGC than non-injected or anti-EGFP-injected controls (approximately 2- to 3-fold, respectively). Anti-Bax-siRNA-injected retinas showed a trend towards an increased RGC number (not significant). Regulation of target proteins in situ could be visualized by immunohistochemical stainings. We conclude that (i) c-Jun and Apaf-1 play major roles in the apoptotic cascade of RGC and may represent useful targets for antiapoptotic strategies in RGC in vivo, and (ii) injection of siRNAs into the optic nerve stump is a new method to down-regulate target genes specifically in RGC.
视神经横断会诱导大鼠视网膜中视网膜神经节细胞(RGC)发生凋亡性退变。即刻早期基因c-Jun、促凋亡Bcl-2家族成员Bax以及凋亡小体成分Apaf-1先前已被证明在凋亡级联反应的诱导或执行中起主要作用。在本研究中,我们设计并制备了针对c-Jun、Bax和Apaf-1的小干扰RNA(siRNA),将其注入视神经残端以抑制轴突切断诱导的凋亡。首先在体外测试siRNA以确保沉默效率。在体内,在视网膜铺片中可以观察到Cy3标记的siRNA明显的神经元定位。注射抗Apaf-1和抗c-Jun-siRNA的视网膜显示存活的RGC比未注射或注射抗EGFP的对照组明显更多(分别约为2至3倍)。注射抗Bax-siRNA的视网膜显示RGC数量有增加的趋势(不显著)。通过免疫组织化学染色可以观察到原位靶蛋白的调节。我们得出结论:(i)c-Jun和Apaf-1在RGC的凋亡级联反应中起主要作用,可能是体内RGC抗凋亡策略的有用靶点;(ii)将siRNA注入视神经残端是一种在RGC中特异性下调靶基因的新方法。